SAMG vs XOMA
SAMG: Silvercrest is a boutique wealth and asset management firm providing customized investment strategies and family office services to high-net-worth clients. XOMA: A lean-infrastructure royalty aggregator that generates non-dilutive capital for biotech developers in exchange for long-duration milestone and royalty rights across a diversified 120+ asset portfolio spanning oncology, rare disease, and specialty therapeutics.
Side-by-side fundamentals
| Metric | SAMG | XOMA | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $10.09 | $40.17 | |
| Market cap as of 2026-07-23 | $116M | $710M | |
| P/E as of 2026-07-23 | 43.71 | 21.00 | XOMA lower |
| Net margin as of 2026-07-23 | +2.1% | +69.6% | XOMA higher |
| Gross margin as of 2026-07-23 | n/a | +100.0% | |
| Operating margin as of 2026-07-23 | +4.6% | +61.3% | XOMA higher |
| ROE as of 2026-07-23 | +4.8% | +32.4% | XOMA higher |
| ROA as of 2026-07-23 | +1.7% | +13.1% | XOMA higher |
| Debt / equity as of 2026-07-23 | 0.22 | 0.91 | SAMG lower |
| Revenue growth (YoY) as of 2026-07-23 | +0.5% | +13.2% | XOMA higher |
| Revenue CAGR (3y) SEC XBRL | +0.6% | +105.3% | XOMA higher |
| Dividend yield as of 2026-07-23 | +8.6% | +0.8% | SAMG higher |
| Beta as of 2026-07-23 | 0.68 | 0.88 | |
| 1-year return as of 2026-07-22 close | -40.7% | +48.0% | XOMA higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.